Get the latest Science News and Discoveries

FDA Clears First-of-Its-Kind Nonmedication Treatment for PTSD

The FDA has cleared a system that uses brain activity data to personalize magnetic stimulation for PTSD, adding a new nonmedication treatment option.

None

Related news:

FDA approves daraxonrasib for metastatic pancreatic cancer following landmark clinical trial led by Dana-Farber

Using FDA addiction science, researcher asks: Do salty, high-fat foods act like drugs?

Critical Path for Parkinson’s announces milestone publication highlighting FDA support for novel biomarker to advance precision medicine strategies